Kathrin Eismann

Therapeutic Vaccination of HIV-1-Infected Patients on Haart with a Recombinant HIV-1 <i>Nef</i>-Expressing Mva: Safety, Immunogenicity and Influence on Viral Load during Treatment Interruption

Ellen G. Harrer, Michael Bäuerle, Barbara Ferstl et al. · Antiviral Therapy · 2005 · 103 citations · Full text

Vaccination, Therapeutic Vaccination, Human Retrovirus +14

Dual Selection Pressure by Drugs and HLA Class I-Restricted Immune Responses on Human Immunodeficiency Virus Type 1 Protease

Sandra M. Mueller, Birgit Schaetz, Kathrin Eismann et al. · Journal of Virology · 2007 · 31 citations · Full text

Immunodeficiencies, Immunology, Immunodominance +18

A conserved HLA B13-restricted cytotoxic T lymphocyte epitope in Nef is a dominant epitope in HLA B13-positive HIV-1-infected patients

Ellen G. Harrer, Silke Bergmann, Kathrin Eismann et al. · AIDS · 2005 · 21 citations

Influence of Major HIV-1 Protease Inhibitor Resistance Mutations on CTL Recognition

Sandra M. Mueller, Bernd M. Spriewald, Silke Bergmann et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 15 citations

Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNA

Christian Hofmann, Thomas Harrer, Verena Kubesch et al. · AIDS · 2008 · 11 citations